Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Director/PDMR Shareholding

28 Mar 2025 09:29

RNS Number : 6863C
Macfarlane Group PLC
28 March 2025
 

Macfarlane Group PLC

28th March 2025

 

Macfarlane Group PLC

Director / PDMR Shareholding

Macfarlane Group PLC (LON: MACF) announces that on 26th March 2025 the following persons discharging managerial responsibilities ('PDMRs') acquired ordinary shares of 25 pence each in the Company ("Shares") for nil consideration upon the maturity of the 27th March 2023 awards under the Company's 2022 Deferred Bonus Share Plan ("DBSP"), together with details of the subsequent sale of certain shares automatically arranged on their behalf in accordance with the terms of the DBSP to satisfy related income tax and national insurance liabilities:

PDMR

 

Number of Shares acquired for nil cost (including those added for in respect of dividend equivalent)

 

Number of Shares sold to satisfy income tax and national insurance

Number of Shares retained post sale

Total number of Shares held in the Company

% held of Company's issued share capital

Peter Atkinson

 

64,596

29,128

35,468

1,513,456

0.95%

Ivor Gray

 

31,357

15,397

15,960

303,324

0.19%

 

The Company has been informed that today, the Company's employee benefit trust (the "EBT") purchased 44,525 Shares at an average price of 104.50 pence per Share to help satisfy any future exercise of share options. As a result, the EBT now holds 278,640 Shares in the Company which is approximately 0.17% of the Company's issued share capital.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Settlement of award under the Company DBSP acquired for nil consideration.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. Nil

2. Nil

64,596 ordinary shares

31,357 ordinary shares

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

Nil

e)

Date of the transaction

26 March 2025

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Disposals arranged by the Company's employee benefit trust to cover income tax and national insurance liabilities

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. 104.50 pence

2. 104.50 pence

 

 

29,128 ordinary shares

15,397 ordinary shares

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

e)

Date of the transaction

26 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Aleen Gulvanessian Chair

Peter Atkinson Chief Executive

Ivor Gray Finance Director

 

Spreng Thomson

Callum Spreng

Mob: 07803 970103

 

 

Notes to Editors:

· Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange plc (LSE: MACF) since 1973, with over 70 years' experience in the UK packaging industry.

· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high-quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:

 o Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

 o Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 43 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.

· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines, supplying to a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence; medical; automotive; and aerospace.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDXLDDDGUI
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20263:30 pmRNSExtension of Share Buyback Programme
12th May 20263:28 pmRNSResult of AGM
12th May 20267:00 amRNSAGM Trading Update
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
6th May 20262:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSNotice of AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:40 amRNSDirector/PDMR Shareholdings
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202612:12 pmRNSDirector/PDMR Shareholdings
2nd Mar 20268:26 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSAnnual Results 2025
23rd Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:02 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:01 amRNSNotice of Results & Investor Presentation
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTrading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20258:27 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 202511:57 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.